Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Cancer Medicine|July 4, 2015
Blockade of CD82 by a monoclonal antibody potentiates anti-leukemia effects of AraC in vivoChie Nishioka, Takayuki Ikezoe, Akihito YokoyamaLeukemia Research|April 13, 2016
BCR/ABL increases EZH2 levels which regulates XIAP expression via miRNA-219 in chronic myeloid leukemia cellsChie Nishioka, Takayuki Ikezoe, Jing Yang, et al.Apoptosis : an International Journal on Programmed Cell Death|June 14, 2013
Over-expression of Mcl-1 impairs the ability of ATRA to induce growth arrest and differentiation in acute promyelocytic leukemia cellsJing Yang, Takayuki Ikezoe, Chie Nishioka, et al.International Journal of Hematology|December 17, 2009
p53 is critical for the Aurora B kinase inhibitor-mediated apoptosis in acute myelogenous leukemia cellsTakayuki Ikezoe, Jing Yang, Chie Nishioka, et al.Plos One|May 9, 2015
Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia CellsChie Nishioka, Takayuki Ikezoe, Jing Yang, et al.Apoptosis : an International Journal on Programmed Cell Death|March 12, 2010
Inhibition of MEK/ERK signaling induces apoptosis of acute myelogenous leukemia cells via inhibition of eukaryotic initiation factor 4E-binding protein 1 and down-regulation of Mcl-1Chie Nishioka, Takayuki Ikezoe, Jing Yang, et al.Apoptosis : an International Journal on Programmed Cell Death|June 24, 2009
Inhibition of MEK signaling enhances the ability of cytarabine to induce growth arrest and apoptosis of acute myelogenous leukemia cellsChie Nishioka, Takayuki Ikezoe, Jing Yang, et al.Leukemia Research|October 30, 2012
A novel treatment strategy targeting shugoshin 1 in hematological malignanciesJing Yang, Takayuki Ikezoe, Chie Nishioka, et al.Leukemia Research|February 21, 2012
Thrombomodulin-induced differentiation of acute myelomonocytic leukemia cells via JNK signalingJing Yang, Takayuki Ikezoe, Chie Nishioka, et al.Immunology|January 26, 2008
DHMEQ, a novel nuclear factor-kappaB inhibitor, induces selective depletion of alloreactive or phytohaemagglutinin-stimulated peripheral blood mononuclear cells, decreases production of T helper type 1 cytokines, and blocks maturation of dendritic cellsChie Nishioka, Takayuki Ikezoe, Yang Jing, et al.Pageof 5